Connect with us

News

Shots Fired In Riverside Meadows

Published

1 minute read

By Sheldon Spackman

Red Deer City RCMP are investigating after shots were fired in the Riverside Meadows neighbourhood late last week.

It happened around 12:30am on Friday, October 28th when Mounties responded to reports of shots being fired in the area of 59 Street and 58 Avenue. Police contained the area and located a number of shell casings.

The, four hours later, Police were called to the same area where a group of males were reported to be causing a disturbance and one said to be carrying a handgun. RCMP arrested two men without incident and the third was taken into custody after a brief foot chase. A loaded handgun was seized at the scene.

Mounties believe the shots were fired after an altercation between two groups of people who knew each other and that this was not a random event. No one was injured and RCMP continue to investigate and look for witnesses.

If you have any information regarding these events, call Red Deer RCMP at 403-343-5575. If you wish to remain anonymous, call Crime Stoppers at 1-800-222-8477 or report it online.

(Photo courtesy of Alberta RCMP)

Follow Author

Top Story CP

CFL leaves door open for Argos' quarterback Bethel-Thompson playing in East final

Published on

TORONTO — The CFL has left the door open to McLeod Bethel-Thompson playing in the East Division final Sunday.

The Toronto Argonauts starting quarterback was held out of practice and sent home Friday after attending the Toronto Raptors 97-93 home win over the Milwaukee Bucks on Thursday night.

That violated the CFL’s COVID-19 protocol, which would’ve normally meant Bethel-Thompson having to quarantine for four days and provide two negative tests before being able to resume team activities.

But Toronto hosts the Hamilton Tiger-Cats in the conference final Sunday afternoon at BMO Field.

The CFL announced Friday afternoon Bethel-Thompson will be allowed to play Sunday if he produces negative COVID testing following a 48-hour quarantine at his residence.

Argos Dexter McCoil, Charleston Hughes, Llevi Noel and Jeff Richards also attended the basketball game and will be subject to the same requirements as Bethel-Thompson.

Toronto (9-5) finished atop the East Division standings to secure home-field advantage for the conference final.

Bethel-Thompson was 7-2 as Toronto’s starter this season.

Both the Argos and Raptors are owned by Maple Leafs Sports & Entertainment.

If Bethel-Thompson can’t play, Antonio Pipkin will start for Toronto on Sunday.

The six-foot-three, 225-pound Pipkin started Toronto’s season-ending 13-7 home loss to Edmonton on Nov. 16, completing 10-of-22 passes for 111 yards and an interception while rushing for 78 yards and a TD on nine carries.

Video of Bethel-Thompson holding his infant daughter at the NBA game was carried on the Argos’ Twitter account Thursday night but was no longer available Friday.

But it was present long enough for Hamilton receiver Brandon Banks to notice.

“Wow when I tried to go to raptors game the @cfl told me I couldn’t go!” Banks tweeted. “I ain’t snitching but shit fishy ! #Protocol #tier1.”

Bethel-Thompson also appeared on TSN’s broadcast of the Raptors-Bucks game.

TSN is the CFL’s broadcast partner.

“So lemme get this straight,” TSN’s Kayla Grey, who interviewed Bethel-Thompson during the broadcast, tweeted Friday. ” … a starting quarterback goes on a national broadcast to promote an East Final that he is now forced to miss because the league is forcing him to quarantine for going to a game to promote said East Final?

“Baby what a mess.”

This report by The Canadian Press was first published Dec. 3, 2021.

The Canadian Press

Continue Reading

Top Story CP

Canada buying up to 1.5 million courses of oral antiviral drugs to fight COVID-19

Published on

OTTAWA — Procurement Minister Filomena Tassi says Canada has signed agreements to buy up 1.5 million courses of oral antiviral treatment for COVID-19.

The government has signed up for an initial one million courses of antiviral treatment, once Health Canada endorses their safety and efficacy.

Pfizer submitted a request for Health Canada approval earlier this week.

Canada has also purchased 500,000 courses of Merck’s oral antiviral treatment for COVID-19, with the option to purchase another 500,000 once Health Canada approves the drug.

The drugs are designed to block the enzyme essential for viral replication.

Merck’s clinical trial showed a 50 per cent reduced risk of hospitalization or death compared to placebo patients with mild or moderate COVID-19.

This report by The Canadian Press was first published Dec. 3, 2021.

The Canadian Press

Continue Reading

Trending

X